Menu

Articles

The Icelandic Centre for Research funds 61 research projects for 2019

19.03.2019

The Icelandic Centre for Research (Rannis) has funded 61 new research projects for grant year 2019 from a total pool of 359 applications. Funded projects include those from industry, as well as the University of Iceland, Reykjavik University and the National University Hospital. In addition, postdoctoral and doctoral grants were awarded to 27 stude...

Icelandic Biotech Companies to Toronto Health Innovation Week

08.03.2019

The 6th Annual Health Innovation Week in Toronto will take place from April 1-5, 2019. During this week a group of Nordic companies will be visiting Toronto under the auspice of the Nordic-Canada Health Solutions Initiative. This is a collaboration project to assist Nordic healthcare companies with accelerated entry to the Canadian market. Among th...

Kerecis Acquires Swiss Life-Science Company and Gains Reimbursement Approval

25.02.2019

Kerecis, an Icelandic medical device company, announced two big milestones recently pertaining to the Swiss market: first, the acquisition of a Swiss life-science company, Phytoceuticals; second, the approval from Swiss healthcare authorities that the company’s lead product (Kerecis Omega3 Wound) will be reimbursed in Switzerland. As of March 1, 20...

The world’s most influential scientists from Iceland

12.02.2019

Although Iceland is the most sparsely populated country in Europe, it is among the top in the world regarding GDP, human development and scientists in life sciences. In a recent report, 14 researchers from Iceland were included among the most influential scientists in the world, an indicator of the growing strength of the Icelandic scientific commu...

EpiEndo Pharmaceuticals to advance respiratory treatment with €800k fundraising

07.02.2019

EpiEndo Pharmaceuticals received €800k (ISK 110 million) in capital from Icelandic funds, including Brunnur Ventures and existing shareholders. This fund will be used to develop the treatment called “Barriolides” of Chronic Obstructive Pulmonary Disease (COPD). COPD is a common respiratory disease with over 70 million patients globally. Besides res...

Oculis raises a total of $15.5m in an extension of a Series-B

25.01.2019

Oculis, an Iceland-based biotechnology company developing the topical treatment for eye conditions, recently announced the successful fundraising of 15.5-million CHF (equivalent to 15.5-million USD) in an extension of its Series B financing round. This round was led by Tekla Capital Management (Boston) and included the contribution of Nan Fung Life...

Florealis introduces a new herbal remedy for urinary tract infections

23.01.2019

Florealis - an Icelandic pharmaceutical company – has introduced Lyngonia, a non-antibiotic herbal remedy against urinary tract infections (cystitis). Annually, there are around 150 million women worldwide suffering from the attack of repeated urinary tract infections. Antibiotics are the treatment that is usually prescribed for cystitis. However,...

Alvotech & Changchun High & New Technology enter into Joint Venture

08.01.2019

Biopharmaceutical company Alvotech and Changchun High & New Technology (CCHN) have entered into a joint venture. Alvotech, headquartered in Iceland, is developing biosimilar monoclonal antibodies and is the sister company of Alvogen – a global leader in developing, manufacturing and selling generic, brand, over-the-counter and biosimilar products....

Kerecis Partners with MedStar Health Research Institute

10.12.2018

Kerecis, an Icelandic medical device company, and MedStar Health have announced a partnership to begin an Investigational Device Exemption trial on burn wounds using their fish-skin product. This partnership will include a feasibility trial aimed at obtaining FDA approval for a full-fledged clinical trial in the near future. A full clinical trial w...

Icelandic Health Tech Company Wins Nordic Startup Awards

22.11.2018

At the 2018 Grand Finale of the Nordic Startup Awards in Copenhagen, the Icelandic health-tech company Kara received the People’s Choice Award, beating out startups from across the Nordics. In addition to winning the People’s Choice Award, Kara was nominated for three additional categories. In April 2018, Kara completed a $1.5m USD (180-million ISK...

Page 1 of 3 | Next

Get in touch

For further information on the benefits of establishing a business in Iceland please feel free to contact us.